HUTCHMED (China) HCM
NASDAQ HCM
$12.63 +0.07 (+0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2026)

HUTCHMED (China) (HCM) posted quarterly Accumulated Expenses of $197.6 million for Q2 2026, down 10.6% year-over-year from $221.1 million in Q2 2025, and up 635.81% quarter-over-quarter from $26.9 million in Q4 2025.

HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HCM) has reported Accumulated Expenses for 12 consecutive years, with $197.6 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Accumulated Expenses fell 10.6% year-over-year to $197.6 million; the TTM figure through Jun 2026 stood at $197.6 million (down 10.6% YoY), while the FY2025 annual figure was $26.9 million, down 18.18% from the prior year.
  • Accumulated Expenses climbed to $197.6 million in Q2 2026 per HCM's latest filing, from $26.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $34.7 billion in Q4 2023 and bottomed at $26.9 million in Q4 2025.
  • Historically, Accumulated Expenses has averaged $4.0 billion across 5 years, with a median of $221.1 million in 2025.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses surged 102575.61% — and 2024, when it slumped 99.91%.
  • HUTCHMED (China)'s Accumulated Expenses stood at $33.8 million in 2022, then soared by 102575.61% to $34.7 billion in 2023, then plunged by 99.91% to $32.9 million in 2024, then decreased by 18.48% to $26.9 million in 2025, then soared by 635.81% to $197.6 million in 2026.
  • Business Quant data shows HCM's Accumulated Expenses at $197.6 million in Q2 2026, $26.9 million in Q4 2025, and $221.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 HUTCHMED (China) 2.19 Bn 2.19 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 197.63 Mn
Dec 31, 2025 26.86 Mn
Jun 30, 2025 221.06 Mn
Dec 31, 2024 32.95 Mn
Jun 30, 2024 249.22 Mn
Dec 31, 2023 34.73 Bn
Jun 30, 2023 227.21 Mn
Dec 31, 2022 33.83 Mn
Jun 30, 2022 233.61 Mn
Dec 31, 2021 27.07 Mn
Jun 30, 2021 181.61 Mn
Mar 31, 2021 150.33 Mn
Jun 30, 2020 86.99 Mn
Sep 30, 2019 74.75 Mn
Jun 30, 2019 75.57 Mn
Mar 31, 2019 64.16 Mn
Dec 31, 2018 56.33 Mn
Jun 30, 2018 49.67 Mn
Dec 31, 2017 40.95 Mn
Jun 30, 2017 27.65 Mn